Armstrong, A.; Lebwohl, M.; Stein Gold, L.; Jacobson, A. Brodalumab Provides Rapid Onset of Therapeutic Response for Patients With Moderate-to-Severe Psoriasis. J of Skin 2023, 7, s133.